
Nate Silver @NateSilver538
It's weird how this is getting contextualized. The relatively small (not statistically significant?) drop-off in effectiveness in South Africa seems like good news, not the huge decline we saw with Novavax. — PolitiTweet.org
NYT Science @NYTScience
The Johnson & Johnson vaccine's efficacy rate dropped from 72 percent in the United States to just 57 percent in So… https://t.co/oXU5K…